ABSTRACT
CONTENTS 32.1 Introduction ......................................................................................................................565
32.1.1 Monoclonal and Chimeric Antibodies ..........................................................566 32.1.2 Starting Down the Path to Rituxan: High-Level Expression
of Recombinant Proteins ..................................................................................570 32.2 The CHO Cell Line ..........................................................................................................571
